🎙️ RMTG CEO Interview Airing Nationally — Weekend Watchlist Opportunity
For those scanning this weekend for real under-the-radar plays — RMTG is one to know heading into Monday.
The company is gaining visibility fast, with CEO Dave Christensen featured on The Big Biz Show with Sully Sullivan, airing nationally. But this isn’t just about airtime — the business fundamentals behind RMTG are where it gets interesting:
✅ 26 clinics across 21 countries
✅ $4.1M in revenue last year
✅ 70% YoY growth with 69% gross margins
✅ Headquartered in Florida, where a recently passed stem cell bill allows certain regenerative therapies to be administered without full FDA approval
✅ 4 diverse revenue streams, including contracts with physicians to open turnkey treatment centers, trained and fully supplied by RMTG via ISCAA standards
✅ Recurring revenue locked in from patient procedures, equipment sales, training, and biologics
The stock closed Friday at $0.053 x $0.0556 after two green days in a row:
📈 +15% Thursday
📈 +29% Friday
📊 Just 103,000 shares traded Friday — showing how thin this 12.5m share float really is.
If you’re looking for a fundamentally strong story in the regenerative medicine space with fresh exposure and real growth, RMTG should be on your radar before Monday.
— UndervaludeOpportunity
AI
Market Data 
Markets 
